Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

STANFORD UNIVERSITY

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1885-11-11

Employees: 10K

Market Cap: -

Website: http://www.stanford.edu

Clinical Trials

Combination Chemotherapy Plus Low-Dose Radiation Therapy in Treating Patients With Stage I or Stage IIA Hodgkin's Lymphoma

Phase 2

Completed

Conditions: Lymphoma: Hodgkin
Lymphoma, Hodgkin Disease
Hodgkin Disease
Lymphoma

Interventions: Drug: Vincristine
Drug: Cyclophosphamide
Drug: Doxorubicin
Drug: Prednisone
Drug: Bleomycin
Drug: Etoposide
Radiation: Low-dose radiotherapy (RT)

First Posted Date: 2003-01-27

Last Posted Date: 2018-07-24

Lead Sponsor: Stanford University

Target Recruit Count: 76

Registration Number: NCT00026208

Locations: 🇺🇸
Stanford University School of Medicine, Stanford, California, United States
🇺🇸
Kaiser Permanente Medical Center, Vallejo, California, United States

Gefitinib and Combination Chemotherapy in Treating Patients With Advanced Solid Tumors or Colorectal Cancer

Phase 2

Completed

Conditions: Colorectal Cancer

First Posted Date: 2003-01-27

Last Posted Date: 2013-05-15

Lead Sponsor: Stanford University

Registration Number: NCT00025142

Locations: 🇺🇸
Stanford Cancer Center at Stanford University Medical Center, Stanford, California, United States

Combination Chemotherapy in Treating Patients With Advanced Hodgkin's Lymphoma

Phase 2

Completed

Conditions: Lymphoma

Interventions: Biological: Bleomycin sulfate
Drug: Stanford V regimen
Drug: Doxorubicin hydrochloride
Drug: Etoposide
Drug: Mechlorethamine hydrochloride
Drug: Prednisone
Drug: Vinblastine
Drug: Vincristine sulfate

First Posted Date: 2003-01-27

Last Posted Date: 2020-08-12

Lead Sponsor: Stanford University

Target Recruit Count: 50

Registration Number: NCT00002715

Locations: 🇺🇸
Stanford Cancer Center at Stanford University Medical Center, Stanford, California, United States

Bevacizumab in Treating Patients With Myelodysplastic Syndrome

Phase 1

Completed

Conditions: Leukemia
Myelodysplastic Syndromes
Myelodysplastic/Myeloproliferative Neoplasms

First Posted Date: 2003-01-27

Last Posted Date: 2013-05-15

Lead Sponsor: Stanford University

Registration Number: NCT00022048

Locations: 🇺🇸
Arizona Cancer Center at University of Arizona Health Sciences Center, Tucson, Arizona, United States
🇺🇸
Stanford Cancer Center at Stanford University Medical Center, Stanford, California, United States
🇺🇸
University of Texas - MD Anderson Cancer Center, Houston, Texas, United States

Apnea Positive Pressure Long-Term Efficacy Study

Phase 3

Completed

Conditions: Sleep Apnea Syndromes
Sleep
Lung Diseases

Interventions: Device: Active CPAP
Device: Sham CPAP

First Posted Date: 2003-01-13

Last Posted Date: 2018-11-28

Lead Sponsor: Stanford University

Target Recruit Count: 1105

Registration Number: NCT00051363

Locations: 🇺🇸
University of Arizona AHSC, Tucson, Arizona, United States
🇺🇸
Stanford University School of Medicine, Palo Alto, California, United States
🇺🇸
Brigham & Women's Hospital, Boston, Massachusetts, United States

and more 2 locations

Reducing Eating Disorder Risk Factors

Not Applicable

Completed

Conditions: Eating Disorders

Interventions: Behavioral: Web-based intervention to reduce eating disorder risk factors

First Posted Date: 2002-12-17

Last Posted Date: 2020-03-18

Lead Sponsor: Stanford University

Target Recruit Count: 206

Registration Number: NCT00050570

Locations: 🇺🇸
Stanford University, Dept. of Psychiatry and Behavioral Sciences, Stanford, California, United States

Sleep Disordered Breathing, APOE, and Lipid Metabolism

Completed

Conditions: Sleep Apnea Syndromes
Lung Diseases

First Posted Date: 2002-10-01

Last Posted Date: 2014-03-05

Lead Sponsor: Stanford University

Registration Number: NCT00046670

Memory and Mental Health in Aging

Not Applicable

Completed

Conditions: Memory Disorders

First Posted Date: 2002-08-13

Last Posted Date: 2013-12-05

Lead Sponsor: Stanford University

Target Recruit Count: 200

Registration Number: NCT00043589

Locations: 🇺🇸
Aging Clinical Research Center, VA Palo Alto Health Care System, Palo Alto, California, United States

Neighborhood-Level Influences on All-Cause Mortality

Completed

Conditions: Cardiovascular Diseases
Heart Diseases

First Posted Date: 2002-02-28

Last Posted Date: 2013-06-26

Lead Sponsor: Stanford University

Registration Number: NCT00031252

A Dose-Escalating Study of Ro 31-8959 ( HIV Protease Inhibitor ) in Patients With HIV Disease.

Phase 1

Completed

Conditions: HIV Infections

First Posted Date: 2001-08-31

Last Posted Date: 2005-06-24

Lead Sponsor: Stanford University

Target Recruit Count: 32

Registration Number: NCT00002111

Locations: 🇺🇸
Stanford Univ School of Medicine, Stanford, California, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy